GAM Systematic’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$1.99M Buy
66,962
+18,011
+37% +$550K 0.29% 108
2017
Q2
$1.62M Buy
48,951
+7,664
+19% +$241K 0.23% 159
2017
Q1
$1.22M Buy
41,287
+40,567
+5,634% +$1.11M 0.24% 151
2016
Q4
$18K Sell
720
-12,807
-95% -$291K ﹤0.01% 580
2016
Q3
$305K Sell
13,527
-25,003
-65% -$588K 0.06% 448
2016
Q2
$918K Buy
38,530
+4,570
+13% +$110K 0.22% 178
2016
Q1
$807K Buy
33,960
+16,609
+96% +$406K 0.21% 185
2015
Q4
$483K Sell
17,351
-35,520
-67% -$892K 0.14% 301
2015
Q3
$1.09M Buy
+52,871
New +$1.34M 0.25% 141

Other funds holding GMED

GAM Systematic's GMED Position: Q3 2017 in Review

GAM Systematic increased its Globus Medical (GMED) stake by 37% in Q3 2017, buying an estimated $550K and bringing the position to 66,962 shares worth $1.99M. The position accounts for 0.29% of the portfolio, ranked #108.

GAM Systematic first reported a position in GMED in Q3 2015 and has held it in 9 quarters since. 253 funds tracked by Wall St. Rank hold GMED as of Q3 2017.

  • GAM Systematic held 66,962 shares of Globus Medical worth $1.99M as of Q3 2017.
  • GAM Systematic bought 18,011 Globus Medical shares in Q3 2017, an estimated $550K.
  • Globus Medical made up 0.29% of GAM Systematic's portfolio in Q3 2017, its #108 holding.
  • GAM Systematic first reported a position in Globus Medical in Q3 2015 and has held it in 9 quarters since.
  • 253 funds tracked by Wall St. Rank held Globus Medical as of Q3 2017.

Based on GAM Systematic's 13F filing for Q3 2017, filed 14 Nov 2017.